Stay updated with breaking news from Harvard Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Harvard Bioscience, Inc. (NASDAQ:HBIO – Get Free Report) CEO James W. Green acquired 20,000 shares of the business’s stock in a transaction dated Thursday, June 6th. The stock was purchased at an average price of $3.07 per share, with a total value of $61,400.00. Following the acquisition, the chief executive officer now owns 3,101,091 shares […]
16.05.2024 - HOLLISTON, Mass., May 16, 2024 (GLOBE NEWSWIRE) - Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark ...
Strong gross margin performance and focus on efficiency to support ongoing investments in growthHOLLISTON, Mass., May 07, 2024 -- Harvard Bioscience, Inc. today announced financial results for...
HOLLISTON, Mass., April 09, 2024 -- Harvard Bioscience, Inc. today announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth. The...
02.04.2024 - Established a Research Collaboration with the McGowan Institute for Regenerative Medicine at the University of Pittsburgh to Study the Repair and Regeneration of the Colon following ColectomyEstablished a Collaboration with Hugh Taylor, MD, chair of ...